23andMe
potential to more efficiently develop novel therapeutics by power need and speed years average ates years | 23andMe
Company
Deck Type
Sector
Industry
Deck date
February 2022
Slide
28 of 63
Similar slides by 23andMe
See diffirences between slides (animation)
Investor Presentation
August 2022
potential to more efficiently develop novel therapeutics by power need and speed | 23andMe
Investor Day
January 2022
potential to more efficiently develop novel therapeutics by power need and speed years average ats tee | 23andMe
SPAC
February 2021
efficiently develop novel therapeutics by power need and speed mes gee | 23andMe
Related slides by other companies
Nuscale
SPAC
December 2021
visionary management team seg | Nuscale
Vivid Seats
SPAC
April 2021
multiple drivers of potential upside beyond the forecast market rebound | Vivid Seats
BenevolentAI
Investor Presentation
October 2022
how approach compares to industry typical proportion of targets validated by lab assay potential increase in chance of a drug reaching the market industry time from target to candidate yrs potential time saved relative to industry at least yrs cost from target to potential cost bene per relative to industry saving | BenevolentAI
Flutter
Investor Day
August 2021
brand synonymous with the us sports experience bet ates a i a | Flutter
Other recent decks by 23andMe
See all presentations (7 decks)
Investor Presentation
January 2024
Investor Presentation
April 2023
Investor Presentation
August 2022
Investor Day
January 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io